Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba hospital, Malawi

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 92, Issue 3, 1998, Pages 343-347

  Harries, A D ^a,b,e   Nyangulu, D S ^b   Kang'ombe, C ^a   Ndalama, D ^b   Glynn, J R ^c   Banda, H ^a   Wirima, J J ^a   Salaniponi, F M ^b   Liomba, G ^a   Maher, D ^d   Nunn, P ^d  

^a UNIVERSITY OF MALAWI   (Malawi)

^b MINISTRY OF HEALTH   (Malawi)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e British High Commission   (Malawi)

Author keywords

Chemotherapy; Human immunodeficiency virus; Isoniazid; Malawi; Mycobacterium tuberculosis; Pyrazinamide; Rifampicin; Streptomycin; Thiacetazone; Tuberculosis

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWI; MALE; MORTALITY; SERODIAGNOSIS; SPUTUM SMEAR; TREATMENT OUTCOME; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; RNA VIRUSES; UNCULTURED ACTINOMYCETE;

EID: 13144256773     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(98)91036-7     Document Type: Article

References (20)

1. Ackah, A. N., Coulibaly, D., Digbeu, H., Diallo, K., Vetter, K. M., Coulibaly, I. M., Greenberg, A. E. & De Cock, K. M. (1995). Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet, 345, 607-610.
2. Daley, C. L., Mugusi, F., Chen, L. L., Schmidt, D. M., Small, P. M., Bearer, E., Aris, E., Mtoni, I. M., Cegielski, J. P., Lallinger, G., Mbaga, I. & Murray, J. F. (1996). Pulmonary complications of HIV infection in Dar es Salaam, Tanzania. Role of bronchoscopy and bronchoalveolar lavage. American Review of Respiratory and Critical Care Medicine, 154, 105-110.
3. De Cock, K. M., Soro, B., Coulibaly, I. M. & Lucas, S. B. (1992). Tuberculosis and HIV infection in sub-Saharan Africa. Journal of the American Medical Association, 268, 1581-1587.
4. Elliott, A. M., Halwiindi, B., Hayes, R. J., Luo, N., Mwinga, A. G., Tembo, G., Machiels, L., Steenbergen, G., Pobee, J. O. M., Nunn, P. & McAdam, K. P. W. J. (1995). The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 78-82.
5. Elvin, K. M., Lumbwe, C. M., Luo, N. P., Björkman, A., Källenius, G. & Linder, E. (1989). Pneumocystis carinii is not a major cause of pneumonia in HIV infected patients in Lusaka, Zambia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 553-555.
6. Enarson, D. A., Rieder, H. L., Arnadottir, T. & Trebucq, A. (1996). Tuberculosis Guide for Low Income Countries, 4th edition. Paris: International Union against Tuberculosis and Lung Disease.
7. Gilks, C. F., Brindle, R. J., Otieno, L. S., Simani, P. M., Newnham, R. S., Bhatt, S. M., Lule, G. N., Okelo, G. B. A., Watkins, W. M., Waiyaki, P. G., Were, J. B. O. & Warrell, D. A. (1990). Life-threatening bacteraemia in HIV-1-seropositive adults admitted to hospital in Nairobi, Kenya. Lancet, 336, 545-549.
8. Graf, P. (1994). Tuberculosis control in high-prevalence countries. In: Clinical Tuberculosis, Davies, P. D. O. (editor). London: Chapman & Hall Medical, pp. 325-339.
9. Kamanfu, G., Mlika-Cabanne, N., Girard, P-M., Nimubona, S., Mpfizi, B., Cishako, A., Roux, P., Coulaud, J.-P., Larouze, B., Aubry, P. & Murray, J. F. (1993). Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. American Review of Respiratory and Critical Care Medicine, 147, 658-663.
10. Malin, A. S., Gwanzura, L. K. Z., Klein, S., Robertson, V. J., Musvaire, P. & Mason, P. R. (1995). Pneumocystis carinii pneumonia in Zimbabwe. Lancet, 346, 1258-1261.
11. McLeod, D. T., Neill, P., Robertson, V. J., Latif, A. S., Emmanuel, J. C., Els, J. E., Gwanzura, L. K. Z.,Trijssenaar, F. E. J., Nziramasanga, P., Jongeling, G. R., Katzenstein, D. A., Nknaza, N. & Lucas, S. B. (1989). Pulmonary diseases in patients infected with human immunodeficiency virus in Zimbabwe, Central Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 694-697.
12. Nunn, P., Brindle, R., Carpenter, L., Odhiambo, J., Wasunna, K., Newnham, R., Githui, W., Gathua, S., Omwega, M. & McAdam, K. (1992). Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. American Review of Respiratory and Critical Care Medicine, 146, 849-854.
13. Okwera, A.,Whalen, C., Byekwaso, F.,Vjecha, M., Johnson, J., Huebner, R., Mugwera, R., Ellner, J. and the Makerere University - Case Western University Research Collaboration (1994). Randomised trial of thiacetazone and rifampicincontaining regimens for pulmonary tuberculosis in HIV-infected Ugandans. Lancet, 334, 1323-1328.
14. Perriens, J. H., St Louis, M. E., Mukadi, Y. B., Brown, C., Prignot, J., Pouthier, F., Portaels, F., Willame, J. C., Manadala, J. K., Kaboto, M., Ryder, R. W., Roscigno, G. & Piot, P. (1995). Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. New England Journal of Medicine, 332, 779-784.
15. Richter, C., Ndosi, B., Mwammy, A. S. & Mbwambo, R. K. (1991). Extrapulmonary tuberculosis - a simple diagnosis? Tropical and Geographical Medicine, 43, 375-378.
16. Richter, C., Pallangyo, K. J., Ndosi, B. N., Chum, H. J., Swai, A. B. M. & Shao, J. (1994). Chest radiography and β-2 microglobulin levels in HIV-seronegative and HIV-seropositive African patients with pulmonary tuberculosis. Tropical and Geographical Medicine, 46, 283-287.
17. Taelman, H., Kagame, A., Batungwanayo, J., Bogaerts, J., Clerinx, J., Allen, S. & van de Perre, P. (1991). Tuberculosis and HIV infection. British Medical Journal, 302, 1206.
18. Toman, K. (1979). Tuberculosis Case-finding and Chemotherapy. Questions and Answers. Geneva: World Health Organization.
19. WHO (1994). Framework for effective tuberculosis control. Geneva: World Health Organization, mimeographed document WHO/TB/94.179.
20. WHO (1997). Treatment of Tuberculosis: Guidelines for National Programmes, 2nd edition. Geneva: World Health Organization.